| abstract |
The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt thereof.n n n Formula In n n n n n n n Wherein A is an optionally unsaturated 5-or 6-membered ring which may contain a heteroatom selected from N, O and S and which may be substituted by oxo or (1-6C) alkyl,n n n R 1 , R 2 and R 3 are each independently selected from the group consisting of H, (1-6C) alkyl, (1-6C) alkoxy, (1-6C) alkoxy- (1-6C) ;n n n X is O or S;n n n n is 1 or 2,n n n Except for 3- (naphth-1-yl-oxy) -pyrrolidine and 3- (5,6,7,8-tetrahydro-naphth-1-yl-oxy) -pyrrolidine.n n n The compounds of the present invention have antidepressant activity and can be used for the treatment or prevention of serotonin-related diseases. |